Exploring new vaccine strategies to improve infant immunity against infections.
Evaluating mRNA-lipid nanoparticle platforms and adjuvants to overcome maternal antibody interference
This study is looking at how new types of vaccines can work better for babies by figuring out how to get around the protection from their mothers' antibodies, so we can help keep infants safe from infections.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11054286 on NIH RePORTER |
What this research studies
This research investigates how mRNA-lipid nanoparticles and lipid nanoparticle adjuvants can help overcome the interference caused by maternal antibodies in infants. The study aims to analyze immune responses to these new vaccine platforms, focusing on how they can effectively stimulate protective antibody responses in young children. By understanding the interaction between maternal antibodies and vaccines, the research seeks to develop strategies that enhance vaccine efficacy in infants, who are particularly vulnerable to infections. The project is led by a physician-scientist with expertise in immunology and vaccine development.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants who are 0-4 weeks old and are at risk of infections that could be prevented by vaccination.
Not a fit: Patients who are older than 4 weeks or those who do not have maternal antibodies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines for infants, reducing their risk of serious infections.
How similar studies have performed: Previous research has shown promise in using novel vaccine platforms to enhance immune responses, suggesting potential success for this approach.
Where this research is happening
Philadelphia, United States
- Children's Hosp of Philadelphia — Philadelphia, United States (Active)
Researchers
- Principal investigator: England, Ross — Children's Hosp of Philadelphia
- Study coordinator: England, Ross
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.